BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 2445931)

  • 1. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
    Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
    Coia LR; Paul AR; Engstrom PF
    Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
    Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
    Sola B; Airoldi M; Orecchia R; Rovea P; Fracchia F; Boidi Trotti A; Tessa M; Foco A; Oliaro A; Casadio C; Dei Poli M
    Radiol Med; 1996 Apr; 91(4):456-9. PubMed ID: 8643859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
    John M; Flam M; Wittlinger P; Mowry PA
    Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of combined radiotherapy and chemotherapy for esophageal carcinoma.
    Coia LR; Engstrom PF; Paul A; Gallagher MJ; Stoll D; Catalano R; Richter MP
    Am J Clin Oncol; 1984 Dec; 7(6):653-9. PubMed ID: 6084954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Greco FA; Gray JR; Thomas M; Sutton VM; Davis JL; Kalman LA; Shaffer DW; Yost K; Rinaldi DA; Hainsworth JD
    Cancer J; 2003; 9(4):251-60. PubMed ID: 12967135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonoperative therapy for squamous-cell cancer of the esophagus.
    Leichman L; Herskovic A; Leichman CG; Lattin PB; Steiger Z; Tapazoglou E; Rosenberg JC; Arbulu A; Asfaw I; Kinzie J
    J Clin Oncol; 1987 Mar; 5(3):365-70. PubMed ID: 2434626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy of esophageal carcinoma.
    Poplin EA; Khanuja PS; Kraut MJ; Herskovic AM; Lattin PB; Cummings G; Gaspar LE; Kinzie JL; Steiger Z; Vaitkevicius VK
    Cancer; 1994 Aug; 74(4):1217-24. PubMed ID: 8055441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.
    Wright CD; Wain JC; Lynch TJ; Choi NC; Grossbard ML; Carey RW; Moncure AC; Grillo HC; Mathisen DJ
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):811-5; discussion 816. PubMed ID: 9375611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
    Wolf M; Zehentmayr F; Niyazi M; Ganswindt U; Haimerl W; Schmidt M; Hölzel D; Belka C
    Strahlenther Onkol; 2010 Jul; 186(7):374-81. PubMed ID: 20582393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.
    Poplin EA; Jacobson J; Herskovic A; Panella TJ; Valdivieso M; Hutchins LF; Macdonald JS
    Cancer; 1996 Nov; 78(9):1851-6. PubMed ID: 8909302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma.
    Chan A; Wong A; Arthur K
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):59-65. PubMed ID: 2492271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.